FOXA1_VAX2

CAP-SELEX sample VAX2_FOXA1 · 1 runs in PRJEB66722

Organism
Nucleic acid
DNA
Rounds available
R3
Sequences indexed
10,000

Top enriched sequences

More via API →
Sequence Length log2 FC P(active) Class Monotonicity
GTGAGGACCACCACTGAAGCCACACCATCGTCCGAGTAGC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:f5af00668195
40
CAGTAATCACTACCGATACCATTGCGACGATTACACACTT
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:1d56110f1335
40
ACAGCGTAAAGTACATACAATGACAGCTTACATAGCATAT
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:80593b870e4b
40
ACACCACCAACCACCCCGCTCCAAACACCATACAGATAGA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:33f5994c9662
40
TGTACCTGCGTGATACGCATACCTGTCACAGCCTACCTAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:e7712cf05817
40
ATCAAGACACCCGCGAACAACTTTGTACTACTGAACTAAA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:4833f23594f8
40
CACTACAAAACATAATGAATCTCATTATACAAGCGAAACG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:1ea4199222ff
40
TCCGGTAGCTACCCTGCACTCGTCCTCAAGTAGAATTTAG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:a82bd7cb2e83
40
CCCCCTAAGCCACCCCAACTTGTTCGTCGCCACCCACTCC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:f4cce98ad9ba
40
AGAGTTAGGTTAATTGATGTTGCACCTCATTTAACGCCCA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:7c52faee47ba
40
ATCCAACTAGGAGCGAGACATCGCAACCTACTCACCCGCA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:cce96fa9126d
40
AGACGTTAAGACAAGTTAAACAATGCGTACAATATACCGA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:cf4cbace168a
40
TTAGCATGCCAACACCTAGTGATCGAACATAAACGTCACA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:307a6d8e7d9a
40
ATGAGTAGACTAGAGTGACAGCTAATTACCGACATTACTG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:b6a8d1a386a9
40
GTCCCCTCCCTGTTACGCACGGCTAGTCCAAACACCCTCC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:dcf04d77a44a
40
GCTTATCATACTACAACGACTACAACGTCGAATACGCAAG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:af094652d570
40
TGACCTCTGAAATGAGGAAATAATCCCTGCATTCAGTACC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:4a04f9e578b7
40
CCACCCTTGCTACCTAATTACCCTTCATTAACCGTGTTAA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:bd788ecc2149
40
CACTCACGCACACACACCGACTAATTAGCTATTACACCGC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:f06da661c15e
40
TTAGCCAAAGGGATGTAACACACACCTAATAGTCGTCCTT
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:e34d61f055d4
40
ACGAACACATCACAACAACCACCACAACATGCTCCCACCG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:d0ebe7a3318a
40
CGACCAGCCCCTCACTGGACTAAACAGTGTTTTCCCGTTC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:a4f79feb4d79
40
GCGTAACTACGCGCCTCCCGATAAAGTACACACTAATGAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:a6a979bf0a2a
40
CCTCCTCGCGACCTATTACCTTCTTAATTACACACCATTG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:f32344c95f4c
40
CGGTAATGTGGTACAAGACAATACGTTAATGACTGCGTAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:b610c1cdfb98
40
CCTGACACCCACCTTCGCATCCCGGCGCTGAATCAACACC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:8d96f18d5588
40
CTGTTCGGCCGCTACATGATACCATCCCCTGATTGTCGAT
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:0a26dd999548
40
AAATAGGCTTAATAAGACACGATACTTGCTAAACAGATGA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:2ef1830b16b2
40
TTGCCTCATTTAAAGCAAATAGCCGAATTGGAGCCCGCTA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:17a71d982c0f
40
TTGCTCATTAATGGACGCGATGCCGTCCTTAACCACCAAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:bbccb3537a8d
40
GTAAACACATCATGCACGATGAACTACCTAATGACCTTGC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:750df8cd47ba
40
TTAGCCAATGAGCCTAACCGTGTTGGCTCCACGCGTTAAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:b24ce013908f
40
TTAGACATTCTGAACACGCGCTGAGCCTAATAGACACAGT
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:f2fd09a87900
40
CACGCACAGCGCCACGTTAATTGCTTTCCTAATGACCGAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:e9da4d9d58ec
40
GTGGATGACCGAAGACCATGGCCATCTTGTGCGCTACGAA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:51797b6752be
40
TGTCATCACGACCTCCCAACTGCACCTATAATTAGCACTG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:9acdcc0bca18
40
AAGCCACTTAATTAACAGTGAACAATGGAGCAACCTGAGC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:b4ab14a5f7c9
40
GCTCCAGATATACGGTGCCTCCCAACTACGTGCGCTGTCC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:770036e783b1
40
ACGATGGTGAAAGACCCTAATGACCCTCCTTAACCCTGCG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:b9471f1fe30f
40
TCACGTCAAGTCCGTGCGAATCGTAAGTTAATAGGGCGTA
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:0753516040df
40
CCTGTTTACATAGCGACTCTCGTTACTTAGCGCAAATTAG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:44c2b072ca25
40
ATTACCTGAAGGCAGACGTACGCTACGCTGGAGCACACTG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:6a90c059aa17
40
TTACGTGCGGGCAGCGCGTCCTCATAAAGCATAACCAAGG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:91a51ec28f59
40
TTGATGCACTCAGAATAACCTCTACGGAACGACAACACCT
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:84a8d0687a36
40
TCACGCCACTAATGCCTGTCCCCAGTCATTAGCGGTGGGT
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:705dcbff3e0a
40
CGCACCCGATGTGCCGACTGACATTTCGACGTCCTCCTCG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:a404117d0017
40
TGACCTCCACCTCCCTCCATAATCTACCACATGCCTGTTC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:93cd44d30b6f
40
GTACCGTCCGATACAGACGATAATTACATCATACTGTAAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:4da6d15032d8
40
TTACCCTCCCTGTGTAAACAAAACGCAGATAATGTCTGAC
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:dd789ccf5b37
40
AAAATCGAACCAATACACGTTGCGCGACGCGACCACCACG
PANAPTA:P55317:FOXA1_VAX2:PRJEB66722:R3:65f68f536c1d
40

SELEX rounds

R3 ·final